Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 25,862 shares at $65.73 ($1.7M) on 2024-11-11, disclosed to the SEC on 2024-11-13.
Scheduled sale ($1.7M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.73 | 6,604 | $434K | 25.3% |
| 2 | $65.73 | 6,604 | $434K | 25.3% |
| 3 | $67.05 | 5,977 | $401K | 23.3% |
| 4 | $67.05 | 5,977 | $401K | 23.3% |
| 5 | $67.83 | 700 | $47K | 2.8% |
| Total | $66.40 avg | 25,862 |
| $1.7M |
| 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |